Theravance (THRX +4.8%) draws some notice from investors after Sanford Bernstein initiates...

|By:, SA News Editor

Theravance (THRX +4.8%) draws some notice from investors after Sanford Bernstein initiates coverage with an Outperform rating on shares. According to a SEC filing, the biopharmaceutical company also saw some insider buying recently.